Mylan N.V. on Wednesday said it is proposing to buy Dublin-based Perrigo Co. PLC for $205 a share in cash and stock. Perrigo has 147 million shares outstanding, according to FactSet, which would make it a $30 billion deal, if executed. Mylan said the deal would create "a diversified, global pharmaceutical leader with an unmatched commercial and operating platform and a unique, one-of-a-kind profile." The proposal was delivered to Perrigo's chairman on April 6. The offer is equal to a 25% premium over Perrigo's closing price from April 3. Mylan expects the combination to generate 'significant operating synergies". Perrigo shares were up 28% in midday trade, while Mylan shares were up 10%.
Copyright © 2015 MarketWatch, Inc.